Showing results (441-450 of 504) with videos related to
Sort By:
Pageof 51
Radiation Oncology (London, England)|January 20, 2021
The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapyQiao-Xuan Wang, Rong Zhang, Wei-Wei Xiao, et al.Nature Communications|October 19, 2023
De novo genome assembly depicts the immune genomic characteristics of cattleTing-Ting Li, Tian Xia, Jia-Qi Wu, et al.JAMA Network Open|December 13, 2021
Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal CarcinomaShuo-Han Zheng, Song-Ran Liu, Hai-Bo Wang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 11, 2023
Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair-Deficient Colorectal CancerBin-Yi Xiao, Xuan Zhang, Tai-Yuan Cao, et al.Journal of Medical Genetics|February 10, 2021
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panelWu Jiang, Lin Li, Chuan-Feng Ke, et al.Diseases of the Colon and Rectum|April 29, 2022
Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational StudyKai Han, Jing-Hua Tang, Le-En Liao, et al.Medicine|September 2, 2016
Bevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases: a retrospective cohort studyZhen-Hai Lu, Jian-Hong Peng, Fu-Long Wang, et al.Gastroenterology Report|November 9, 2020
Low prevalence of mismatch repair deficiency in Chinese colorectal cancers: a multicenter studyWu Jiang, Qiao-Qi Sui, Wen-Liang Li, et al.The EMBO Journal|November 20, 2024
FNDC1 is a myokine that promotes myogenesis and muscle regenerationRui Xin Zhang, Yuan Yuan Zhai, Rong Rong Ding, et al.Oncology Reports|March 13, 2026
Silencing of SIVA‑1 promotes cisplatin resistance in gastric cancer via the Bcl‑2/BAX‑mediated mitochondria‑dependent apoptosis pathwayZheng-Yi Shi, Zheng-Rong Ding, Yu-Liang Huang, et al.Pageof 51